The NALCN ion channel is activated by M3 muscarinic receptors in a pancreatic β‐cell line
Open Access
- 3 July 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in EMBO Reports
- Vol. 10 (8), 873-880
- https://doi.org/10.1038/embor.2009.125
Abstract
A previously uncharacterized putative ion channel, NALCN (sodium leak channel, non‐selective), has been recently shown to be responsible for the tetrodotoxin (TTX)‐resistant sodium leak current implicated in the regulation of neuronal excitability. Here, we show that NALCN encodes a current that is activated by M3 muscarinic receptors (M3R) in a pancreatic β‐cell line. This current is primarily permeant to sodium ions, independent of intracellular calcium stores and G proteins but dependent on Src activation, and resistant to TTX. The current is recapitulated by co‐expression of NALCN and M3R in human embryonic kidney‐293 cells and in Xenopus oocytes. We also show that NALCN and M3R belong to the same protein complex, involving the intracellular I–II loop of NALCN and the intracellular i3 loop of M3R. Taken together, our data show the molecular basis of a muscarinic‐activated inward sodium current that is independent of G‐protein activation, and provide new insights into the properties of NALCN channels.Keywords
This publication has 75 references indexed in Scilit:
- Peptide neurotransmitters activate a cation channel complex of NALCN and UNC-80Nature, 2008
- Soy intake and breast cancer risk in Singapore Chinese Health StudyBritish Journal of Cancer, 2008
- Dietary flavonoid intake and risk of cancer in postmenopausal women: The Iowa Women's Health StudyInternational Journal of Cancer, 2008
- Ion Channels as Drug Targets: The Next GPCRsThe Journal of general physiology, 2008
- The role of early life genistein exposures in modifying breast cancer riskBritish Journal of Cancer, 2008
- Soy intake and breast cancer: elucidation of an unanswered questionBritish Journal of Cancer, 2008
- Epidemiology of soy exposures and breast cancer riskBritish Journal of Cancer, 2008
- Genistein sensitizes inhibitory effect of tamoxifen on the growth of estrogen receptor‐positive and HER2‐overexpressing human breast cancer cellsMolecular Carcinogenesis, 2007
- Soy phytochemicals synergistically enhance the preventive effect of tamoxifen on the growth of estrogen-dependent human breast carcinoma in miceCarcinogenesis: Integrative Cancer Research, 2007
- Estrogen Carcinogenesis in Breast CancerNew England Journal of Medicine, 2006